APOE and Alzheimer disease: No statistically significant interaction was observed between age group and ApoE4 carrier status in any of the ROIs examined except the thalamus (F1,128 = 4.74, p = 0.035); the presence of the ApoE4 allele increased the amyloid levels in younger AD patients but not in the older group.